Bridge­Bio bor­rows $750M ahead of key PhI­II read­out, as it looks to wrap up buzzy 2021

The way Bridge­Bio tells it, it’s been up to some big things re­cent­ly. And on Thurs­day, the biotech just got a whole lot more cash to turn its dreams in­to re­al­i­ty.

Bridge­Bio took out a $750 mil­lion loan on Thurs­day, sep­a­rat­ed in­to two tranch­es of $450 mil­lion and $300 mil­lion. The first, larg­er tranche will be avail­able for Bridge­Bio to spend im­me­di­ate­ly, while the biotech can opt in­to the sec­ond, small­er tranche af­ter one of two con­di­tions re­lat­ed to its pipeline is met.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER